Market Research Logo

Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review

Venaxis, Inc. (APPY) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains crit

    ical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Venaxis, Inc. (Venaxis) is an in-vitro diagnostic company focusing on development of blood-based tests in the diagnosis and treatment of acute appendicitis (AA) in children adolescent and young adult patients. Its product portfolio comprises APPY1 System which consists of a small fluorometer and consumable test products. APPYReader instrument is the fluorometer used in the system, while the test products include APPY1 Test, APPYReader QC Cassette, and APPY1 Controls. The system helps physicians to identify low disease risk for adolescent and children patients. The APPY1 System has received the CE marking in Europe. Venaxis is headquartered in Castle Rock, Colorado, the US.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Venaxis, Inc. - Key Facts
Venaxis, Inc. - Key Employees
Venaxis, Inc. - Key Employee Biographies
Venaxis, Inc. - Major Products and Services
Venaxis, Inc. - Medical Equipment Pipeline Products Data
Venaxis, Inc. Pipeline Products by Equipment Type
Venaxis, Inc. Pipeline Products by Development Stage
Venaxis, Inc. - History
Venaxis, Inc. - Company Statement
Venaxis, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Venaxis, Inc. - Business Description
Venaxis, Inc. - Corporate Strategy
Venaxis, Inc. - SWOT Analysis
SWOT Analysis - Overview
Venaxis, Inc. - Strengths
Strength - Research and Development
Strength - Proprietary Acute Appendicitis Testing Technology
Venaxis, Inc. - Weaknesses
Weakness - Limited Customer Base
Weakness - History of Losses
Venaxis, Inc. - Opportunities
Opportunity - Positive Outlook of Medical Device Industry
Opportunity - Medical Need for Appendicitis
Opportunity - IVD Market
Venaxis, Inc. - Threats
Threat - Intense Competition
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Uncertain R&D Outcomes
Venaxis, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Venaxis, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Venaxis, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Venaxis, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 29, 2015: Venaxis Receives FDA “Not Substantially Equivalent” Response on APPY1 510(k) Submission
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Venaxis, Inc., Key Facts
Venaxis, Inc., Key Employees
Venaxis, Inc., Key Employee Biographies
Venaxis, Inc., Major Products and Services
Venaxis, Inc. Number of Pipeline Products by Equipment Type
Venaxis, Inc. Pipeline Products by Equipment Type
Venaxis, Inc. Number of Pipeline Products by Development Stage
Venaxis, Inc. Pipeline Products by Development Stage
Venaxis, Inc., History
Venaxis, Inc., Key Competitors
Venaxis, Inc., Ratios based on current share price
Venaxis, Inc., Annual Ratios
Venaxis, Inc., Interim Ratios
Venaxis, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Venaxis, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016
Venaxis, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Venaxis, Inc. Pipeline Products by Equipment Type
Venaxis, Inc. Pipeline Products by Development Stage
Venaxis, Inc., Performance Chart (2011 - 2015)
Venaxis, Inc., Ratio Charts
Venaxis, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Venaxis, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report